Prognostic value of maximum standardized uptake values from preoperative positron emission tomography in resectable adenocarcinoma of the esophagus treated by surgery alone

Diseases of the Esophagus

Volumn 22, Issue 8, 2009, Pages 668-675

  Shenfine, J ^a   Barbour, A P ^b   Wong, D ^b   Thomas, J ^b   Martin, I ^b   Gotley, D C ^b   Smithers, B M ^b  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Cancer; Cancer staging; Esophagectomy; Esophagus; Positron emission scanning

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; DISEASE FREE SURVIVAL; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; HUMAN; LOWER ESOPHAGUS SPHINCTER; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PROGNOSIS; SCINTISCANNING; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PROGNOSIS; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS;

EID: 77649280486     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2009.00941.x     Document Type: Article

References (20)

1. Barbour A P, Rizk N P, Gerdes H et al. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction. J Am Coll Surg 2007; 205 (4): 593-601.
2. Vickers J, Alderson D. Oesophageal cancer staging using endoscopic ultrasonography. Br J Surg 1998; 85 (7): 994-8.3
3. Kelly S, Harris K M, Berry E et al. A systematic review of the staging performance of endoscopic ultrasound in gastrooesophageal carcinoma. Gut 2001; 49 (4): 534-9.
4. Greene F L. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 2002; 87 (7): 13-5.
5. Sobin L H, Wittekind C. TNM Classification of Malignant Tumours, 6th edn. Hoboken, NJ: John Wiley & Sons, 2002.
6. Westreenen H L, Heeren P A, van Dullemen H M et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 2005; 9 (1): 54-61.
7. Kato H, Kuwano H, Nakajima M et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002; 94 (4): 921-8.
8. Choi J Y, Lee K H, Shim Y M et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 2000; 41 (5): 808-15.
9. Cerfolio R J, Bryant A S. Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival. Ann Thorac Surg 2006; 82 (2): 391-4. discussion 4-5.
10. Rizk N, Downey R J, Akhurst T et al. Preoperative 18Ffluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 2006; 81 (3): 1076-81.
11. Rudiger Siewert J, Feith M, Werner M, Stein H J. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000; 232 (3): 353-61.
12. Gebski V, Burmeister B, Smithers B M, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a metaanalysis. Lancet Oncol 2007; 8 (3): 226-34.
13. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359 (9319): 1727-33.
14. Kelsen D P, Ginsberg R, Pajak T F et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339 (27): 1979-84.
15. Fukunaga T, Okazumi S, Koide Y, Isono K, Imazeki K. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J Nucl Med 1998; 39 (6): 1002-7.
16. Esteves F P, Schuster DM, Halkar R K. Gastrointestinal tract malignancies and positron emission tomography: an overview. Semin Nucl Med 2006; 36 (2): 169-81.
17. Choi J Y, Jang H J, Shim YM, et al. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications. J Nucl Med 2004; 45 (11): 1843-50.
18. Smithers B M, Couper G C, Thomas J M et al. Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus. Dis Esophagus 2008; 21 (2): 151-8.
19. Little S G, Rice T W, Bybel B et al. Is FDG-PET indicated for superficial esophageal cancer?. Eur J Cardiothorac Surg 2007;(5): 791-6.
20. Van Dam J, Rice TW, Catalano MF, Kirby T, Sivak MV, Jr. High-grade malignant stricture is predictive of esophageal tumor stage. Risks of endosonographic evaluation. Cancer 1993; 71 (10): 2910-7.